Synlait Milk (ASX:SM1): FY26 Loss, Refinancing and Recovery Milestones

Aditi Sarkar

02 November 2026 06:03 PM AEDT

Synlait Milk (ASX:SM1): FY26 Loss, Refinancing and Recovery Milestones

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Synlait Milk (ASX:SM1) was quoted at AUD 0.395, down 4.82%, in the share-price figures for 2 November 2026.
FY26 Revenue reached NZD 1.94 billion, while the reported net loss after tax was NZD 75.4 million.
Reported second-half EBITDA was NZD 42.8 million following a first-half loss of NZD 34.7 million.
Synlait reported NZD 215.0 million net Debt and outlined its five-month transitional reporting period.

Synlait Milk Limited (ASX:SM1) processes milk into ingredients, nutritional products and consumer-oriented dairy offerings in New Zealand. On 2 November 2026, the shares were priced at AUD 0.395, a decline of 4.82% in the stated market figures. The company’s September 2026 annual results reported a full-year loss despite a return to positive reported Earnings before interest, tax, Depreciation and Amortisation (EBITDA). Synlait also completed financing arrangements and appointed a permanent chief executive during 2026, as it continued a programme focused on Manufacturing consistency and its financial position.

Company Business and Operating Model

Synlait Milk Limited (ASX:SM1) operates in dairy processing, producing ingredients and advanced nutritional products for customers and markets beyond New Zealand. Its stated areas of commercial focus include Advanced Nutritionals, Ingredients, Foodservice and Consumer channels. The company is concentrating on its Canterbury manufacturing Assets following its completed sale of North Island assets in April 2026.

Recent Developments and Manufacturing Recovery

In its September 2026 annual results, Synlait Milk Limited (ASX:SM1) reported improved manufacturing indicators during the second half. Manufactured in Spec increased from 91% in the first half to 95% in the second; the metric averaged 99% in August. Plan attainment increased from 90% to 103% across the same half-year comparison. These indicators measure elements of plant execution, although they do not by themselves establish the profitability of individual products or contracts.

In June 2026, Synlait documented new bank funding facilities totalling NZD 320 million and a replacement NZD 130 million Shareholder loan. The facilities carry Maturity schedules, financial covenants and requirements around Working Capital and interest cover. On 21 October 2026, the company appointed Leon Fung as permanent chief executive, following his appointment in an acting capacity in May. Operational priorities remain centred on consistent production, product and customer mix, and management of financial obligations.

FY26 Financial Performance and Dairy-Sector Considerations

For the twelve months ended 31 July 2026, Synlait Milk Limited (ASX:SM1) recorded revenue of NZD 1.94 billion and Gross Profit of NZD 37.7 million. Reported EBITDA was NZD 8.1 million, compared with underlying EBITDA of NZD 46.3 million. The reported net loss after tax was NZD 75.4 million; the underlying net loss was NZD 21.6 million. These reported and underlying measures are different definitions and should not be treated interchangeably.

Reported EBITDA moved from negative NZD 34.7 million in the first half to positive NZD 42.8 million in the second. Reported net profit after tax similarly moved from a NZD 80.6 million first-half loss to a NZD 5.2 million second-half profit. At year-end, Synlait reported net debt of NZD 215.0 million. These figures show the scale of its first-half losses as well as the improvement reported later in the year.

Risks and What to Watch Next

Synlait Milk Limited (ASX:SM1) remains exposed to manufacturing interruptions, product specifications, customer concentration, milk costs, financing covenants and working-capital fluctuations. A return to positive second-half earnings does not eliminate the reported full-year loss or net debt. Funding arrangements include facilities with maturities in 2027, and compliance with lender conditions will remain important.

Key Insights

Synlait Milk Limited (ASX:SM1) reported a full-year statutory loss for FY26, alongside a positive second-half result and improved manufacturing indicators. Its asset sale, refinancing and management changes provide additional context for the ongoing restructuring of operations. Future disclosures on profitability, net debt, production outcomes and covenant compliance will clarify whether the operating changes are sustained.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.